Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Hematology|April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomesMayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Leukemia & Lymphoma|June 22, 2017
Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)Srinivasa R Sanikommu, Michael J Clemente, Peter Chomczynski, et al.
Leukemia & Lymphoma|August 31, 2017
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationAllison Winter, Lisa Rybicki, Shetal N Shah, et al.
Bone Marrow Transplantation|September 12, 2023
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphomaGabriel F P Aleixo, Wei Wei, Po-Hao Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2019
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell TransplantationBrian T Hill, Lisa A Rybicki, Theresa A Urban, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 8, 2022
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoringKelly J Gaffney, Theresa A Urban, Mariana Lucena, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantationWilliam Blum, Brian J Bolwell, Gary Phillips, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution ExperienceYazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Pageof 8